Go behind the scenes of LogiPharma USA 2026 with program director Charleen Ring and McKesson's Chris Van Norman in this Pharma Pulse special.
Commentary|Podcasts|December 22, 2023
Treating Psoriasis While Providing Patient Support
Author(s)Nicholas Saraceno, Senior Editor
Camille Lee discusses the impact of commercial availability of Bimzelx for the treatment of moderate-to-severe plaque psoriasis in adults, along with the value of patient assistance/affordability programs.
Advertisement
In this PC Podcast interview that originally aired for Pharmaceutical Executive, Camille Lee, UCB’s SVP and US head of immunology, dives into:
- The history behind UCB's work in psoriasis
- The significance behind UCB announcing the commercial availability of Bimzelx for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.
- How Bimzelx Navigate can be utilized as a resource for patients on this drug
- What listeners should keep an eye out for in terms of UCB's rheumatology pipeline
The latest episode of The Pharmaceutical Commerce Podcast is available directly on SoundCloud. The original video footage by Associate Editor Don Tracy can be viewed
Advertisement
Related to this article
In this week's Pharma Pulse, DHL breaks ground on a new cold chain hub at Singapore's Changi Airport, a new report finds pharma's commercial model in the middle of a fundamental reset, and the FDA grants accelerated approval to sevabertinib.
In this week's Pharma Pulse, nine more drugmakers join the MFN program, GoodRx adds a family plan, IPC formalizes its USave partnership, and CSafe expands its thermal cover offerings.
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
How Rebate Timing Distorts a Pharmacy's 340B Books
2
EU Pharma Reform: Strategic Implications for US Drugmakers
3
White House Extends MFN Pricing to Every State Medicaid Program
4
Pharma Pulse: Behind the Scenes of LogiPharma USA 2026
5